#168USNYSE

APH

Amphenol

$86.19USD

Data as of 2026-10-14

Composite Score62.5Strong

−49

Margin of safety−49%Overvalued

Fair value$57.72

Target$88.67

Loss chance58%Neutral

SizeMega cap

SectorInformation Technology

Dividend0.58%

TypeCommon stock

Price

Pillar breakdown

0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)

Information Technology median (n=191)

Quality
Profit margins & asset efficiency
72
Exceptional
Information Technology median (n=191) 49
Value
Price vs fundamentals
37
Weak
Information Technology median (n=191) 51
Growth
Revenue & earnings trajectory
72
Exceptional
Information Technology median (n=191) 51
Momentum
Recent price strength
79
Exceptional
Information Technology median (n=191) 54
Health
Balance sheet & solvency
72
Exceptional
Information Technology median (n=191) 65
Profitability
ROE, ROA, ROIC
56
Strong
Information Technology median (n=191) 50
Technical
Trend & volatility signals
50
Average
Information Technology median (n=191) 56
Risk
Volatility & drawdown profile
61
Strong
Information Technology median (n=191) 41

025405570100

Exceptional (70+)Strong (55–70)Average (40–55)Weak (25–40)Poor (<25)

Pillars not shown: Sentiment, ML (Phase 5+).

Risk Summary

1 active

Rank gates

Net share issuance — top decile[net_issuance_top_decile]Top-decile net issuance over the trailing year (Pontiff-Woodgate 2008 / Daniel-Titman 2006).

These flags keep the raw composite rank (project Rule 16) but forfeit the entered_top5 badge. Two of them — altman_distress and data_quality_input_corruption — additionally force a cautious recommendation; the others act as Top-5 disqualifiers without dictating the buy/hold/sell label on their own.

Manipulation index

Low

3/100

Composite penalty: −0.30 pts (informational; rank uses raw composite)

Also fired — not rank-gating (1)

Beneish M-score warning band[beneish_high]

Rolls up Phase 4.5 earnings-manipulation defenses (Sloan · Beneish · Dechow · REM · restatement · late-filing · earnings- quality time-series) into a single 0-100 risk index. The soft composite penalty (max 10 pts) is informational only — the ranking uses the raw composite score per project Rule 16.

Fair price check

4 different valuation methods each estimate what APH should be worth, then we compare to today's price.

Looks overvalued

Models suggest APH is trading above fair value

Today's price

$86.19

Median fair price

$57.72

-33% vs today's price

Of 3 methods:2 say fair1 say pricey(1 outlier excluded)

EV/EBITDAFair
thinks it's fairly priced — estimates $88.67, about 3% above today
P/E multiplesFair
thinks it's fairly priced — estimates $80.02, about 7% below today
P/B multiplesOvervalued
thinks it's expensive — estimates $35.42, about 59% below today
DCF (2-stage)Outlier
estimate looks unreliable — estimates $11.57 — likely unreliable

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair: $57.72
Margin of safety(vs fair value): -49.3%
Max (ex-outliers): $88.67
Tangible BVPS: —

Extreme DCF estimate
Post-split share count adjusted
Beneish M-score (warning band)

Median of all applicable methods (current price $86.19). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.

Supporting dataRaw fundamentals & data-quality provenance behind the scores above

Raw fundamentals (SEC EDGAR)

Metric	Value
Market cap	$212.54B
Revenue (TTM)	$29.01B
Net income (TTM)	$5.19B
Operating cash flow (TTM)	$5.87B
CapEx (TTM)	$1.16B
Free cash flow (TTM)CFO − CapEx	$4.71B
Total assets	$44.81B
Total liabilities	$29.18B
Stockholders' equity	$15.49B
Cash & equivalents	$4.73B
Shares outstanding	2.47B
EPS (basic)	$2.10
EPS (diluted)	$2.10
P/E ratio (TTM)	40.97

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date: 2026-07-31
Latest period end: 2026-07-28
Filing lag: 75 days
Missing metrics: 1(research_and_development)